Mice Harboring a Defective Epidermal Growth Factor Receptor-(Waved-2) Have an Increased Susceptibility to Acute Dextran-Sulfate-induced Colitis

References

• Procaccino F, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, McRoberts JA, et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 1994;107:12–7.
   PubMed Web of Science ®Google Scholar
• Luck MS, Bass P. Effect of epidermal growth factor on experimental colitis in the rat. J Pharmacol Exp Ther 1993;264:984–90.
   PubMed Web of Science ®Google Scholar
• Konturek S, Dembinski A, Warzecha Z, Brzozowski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988;94:1300–7.
   Google Scholar
• Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, Wargovich MJ, et al. Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest 1992;90:2409–21.
   PubMed Web of Science ®Google Scholar
• Polk WH Jr, Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, Barnard JA, et al. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 1992;102:1467–74.
   PubMed Web of Science ®Google Scholar
• Tarnawski A, Stachura J, Durbin T, Sarfeh IJ, Gergely H. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 1992;102:695–8.
   Google Scholar
• Derynck R. The physiology of transforming growth factoralpha. Adv Cancer Res 1992;58:27–52.
   PubMed Web of Science ®Google Scholar
• Carpenter G, Cohen S. Epidermal growth factor. Ann Rev Biochem 1979;48:193–216.
   PubMed Web of Science ®Google Scholar
• Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell 1984;38: 287–97.
   PubMed Web of Science ®Google Scholar
• Scott J, Urdea M, Quiroga M, Sachez-Pescador R, Fong N, Selby M, et al. Structure of mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science 1983;221:236–40.
   Google Scholar
• Bell GI, Fong NM, Stempien MM, Wormsted MA, Caput DA, Ku L, et al. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucl Acids Res 1986;14:8427–46.
   PubMed Web of Science ®Google Scholar
• Derynck R. Transforming growth factor-alpha. Mol Reprod Dev 1990;27:3–9.
   PubMed Web of Science ®Google Scholar
• Hsuan JJ, Panayotou G, Waterfield MD. Structural basis for epidermal growth factor receptor function. Prog Growth Factor Res 1989;1:23–32.
   PubMedGoogle Scholar
• Egger B, Procaccino F, Lakshmanan J, Reinshagen M, Hoffmann P, Patel A, et al. Mice lacking transforming growth factor-alpha have an increased susceptibility to dextran sulfate induced colitis. Gastroenterology 1997;113:825–32.
   PubMed Web of Science ®Google Scholar
• Egger B, Carey HV, Procaccino F, Chai NN, Sandgren EP, Lakshmanan J, et al. Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut 1998;43:64–70.
   PubMed Web of Science ®Google Scholar
• Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694–702.
   PubMed Web of Science ®Google Scholar
• Elson ChO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344–67.
   PubMedGoogle Scholar
• Leung FW, Heng MCY, Allen S, Seno K, Lam K, Leung JWC, et al. Time course of immunological events in dextran sulfate sodium-induced colitis in rats: an immunohistochemical and ultrastructural study [abstract]. Gastroenterology 1997;112 Suppl:A1026.
   Google Scholar
• Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Büchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose/concentration dependency. Digestion 2000;62:240–8.
   PubMed Web of Science ®Google Scholar
• Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993;73:263–78.
   PubMed Web of Science ®Google Scholar
• Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 1993;73:249–61.
   PubMed Web of Science ®Google Scholar
• Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 1994;8:399–413.
   PubMed Web of Science ®Google Scholar
• Helmrath MA, Erwin CR, Warner BW. A defective EGF- receptor in waved-2 mice attenuates intestinal adaptation. J Surg Res 1997;69: 76–80.
   Google Scholar
• Helmrath MA, Shin CE, Erwin CR, Warner BW. The EGFEGF- receptor axis modulates enterocyte apoptosis during intestinal adaptation. J Surg Res 1998;77:17–22.
   PubMedGoogle Scholar
• Yamada M, Ohkusa T, Okayasu I. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 1992;33:1521–7.
   Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228–33.
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 1990;336:357–9.
   PubMed Web of Science ®Google Scholar
• Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110:975–84.
   Google Scholar
• Egger B, Procaccino F, Sarosi I, Tolmos J, Büchler MW, Eysselein VE. Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice. Dig Dis Sci 1999;44:836–44.
   Google Scholar
• Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinico- pathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238–49.
   PubMed Web of Science ®Google Scholar
• Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:259–65.
   PubMedGoogle Scholar
• Onderdonk AB, Steeves RM, Cisneros RL, Bronson RT. Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infect Immun 1984;46:64–7.
   PubMedGoogle Scholar
• Breeling JL, Onderdonk AB, Cisneros RL, Kasper DL. Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs. Infect Immun 1988; 56:1754–9.
   PubMed Web of Science ®Google Scholar
• Sottili M, Sternini C, Reinshagen M, Brecha NC, Nast C, Walsh JH, et al. Up-regulation of transforming growth factor-alpha binding sites in experimental rabbit colitis. Gastroenterology 1995;109:24–31.
   PubMedGoogle Scholar
• Hoffmann P, Zeeh JM, Lakshmanan J, Wu VS, Procaccino F, Reinshagen M, et al. Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats. Gut 1997;41:195–202.
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Stoll R, Lugering N, Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1995;100:452–6.
   PubMed Web of Science ®Google Scholar
• Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996;110: 975–84.
   Google Scholar